The future of medicine will change! FLock.io and AIGEN Science team up to overturn common sense in drug discovery [Comprehensive explanation for beginners]
Hello! I'm John, a blogger who has been writing about the metaverse and the latest technology for many years. Today, I'd like to break down some very exciting news that may revolutionize our future medical care in an easy-to-understand way for everyone. The main players are two companies, FLock.io and AIGEN Sciences. These two companies have teamed up to start a groundbreaking initiative to utilize AI (artificial intelligence) while solving privacy issues in the field of drug discovery. If you think it sounds difficult, don't worry! By the time you finish reading this article, you will surely understand the greatness and potential of this project.
Basic information: What do FLock.io and AIGEN Science solve?
First, let’s take a look at what this project is all about and what problem it’s trying to solve.
- Project Summary: FLock.io and AIGEN Science have formed a strategic partnership to realize AI-based drug discovery while fully protecting privacy.
- Problem it solves: To develop new medicines, it is extremely effective to have AI learn from vast amounts of medical data (such as patient records and clinical trial data). However, this data is the ultimate in personal information. Hospitals and research institutions are very cautious about releasing data to the outside world, fearing the risk of privacy leaks. As a result, there is a "data wall" in which there is a shortage of data for AI to learn from, slowing down the speed of drug discovery research.
- Unique Features: FLock.io's "Distributed Privacy-Preserving AI Learning Infrastructure" breaks down this "data wall." This is a technology that securely collects only the "learning results" necessary for AI, without moving data from hospitals and research institutions where it is stored, rather than collecting data in one place. By combining this technology with AIGEN Science's advanced drug discovery AI engine, it is possible to accelerate drug discovery by utilizing valuable data from around the world while protecting privacy.
Supply details: the token that determines the value of the project
Web3 projects like FLock.io often involve their own digital assets, called "tokens," which are like the fuel that powers the project's ecosystem.
FLock.io may also have its own token, but the project is still in its early stages. At this point, concrete figures such as maximum supply and circulation are often not disclosed. However, it is very important to understand these concepts.
- Max Supply: This is the maximum number of tokens that can be issued in the future. If there is a limit, scarcity will be created and the value will tend to increase (the same idea as gold and Bitcoin).
- Circulating Supply: This is the number of tokens currently on the market. If this number is small, even a slight increase in demand can cause large price fluctuations.
What role will FLock.io's token play (for example, rewards for providers of computing resources, voting rights to decide the direction of the project, etc.) and how the supply amount will be set will be important indicators for measuring the future value of the project. Let's keep an eye on the official announcement in the future.
Technical Mechanism: What is the magic of "federated learning" that protects privacy?
You may not understand what it means to "learn AI without moving data." The core of this technology isFederated Learning" This is the AI's learning method.
Let's compare conventional AI development to the "central library model." Books (data) from all over the world are collected in one huge central library, where a smart librarian (AI) reads them all and learns from them. This is efficient, but there is a risk that books will be lost or stolen when they are moved (privacy violation).
On the other hand, the federated learning adopted by FLock.io isTutoring model".
- First, a copy of the central AI model (the basic learning program) is sent to each hospital or research institution (home) where the data is stored.
- At each location, a copy of the AI is trained using only the data available locally (the books on your bookshelf at home) - none of the data ever leaves the house.
- Once the learning is complete, the smarter parts, that is, the "learning results" (a summary of what was learned), are encrypted and sent back to the central unit.
- At the center, only the "learning results" collected from around the world are integrated to create an even smarter master AI model.
This way, the AI can get smarter without ever seeing the raw data.Blockchain (a technology that links records of transactions and data in a chain, making them extremely difficult to tamper with)This allows for a transparent and fair record of who contributed to what learning, and rewards can be paid automatically and safely. This is a groundbreaking system that truly achieves both privacy and data utilization.
Team and Community: Trusted Experts
No matter how great a technology is, it is the people who make it work. FLock.io and AIGEN Science team are made up of experts in this field, which adds to the credibility of the project.
Of particular note is his appointment as an advisor to the FLock Foundation.Professor Jaewoo KangHe is also the co-founder of AIGEN Science and is known worldwide for his AI research in the fields of medical and life sciences. BioBERT, which he co-developed, is one of the most quoted and well-known AI models in the biomedical field, and there is no doubt that his expertise will be utilized in this project.
In addition, FLock.io actively announces the signing of an MOU (Memorandum of Understanding: an official document promising cooperation) with AIGEN Sciences on its official Twitter account (formerly Twitter) and LinkedIn. In this way, the fact that project progress is regularly shared is reassuring for the community and also evidence that the project is actively moving forward.
Use Cases and Prospects: Drug Discovery and Beyond
The most immediate use case for this project is, of course,Drug discovery".
- Reduced development time: By using AI to rapidly discover candidate drug compounds from vast amounts of data, it has the potential to significantly shorten the development period, which previously took more than 10 years.
- Reduce costs: Shorter development times could reduce huge research and development costs, which could lead to lower drug prices and help more people get the treatments they need.
- Increased chances of success: It is hoped that by making more accurate predictions, AI can increase the success rate of clinical trials, which often fail.
However, the potential of this technology is not limited to drug discovery. In the future, it can also be applied to the following fields:
- Personalized medicine: AI will suggest the optimal treatment plan tailored to an individual's genetic information and lifestyle habits.
- Image diagnosis support: AI will analyze X-rays and CT scan images to support early detection of diseases.
- Finance and Insurance: This will be applied to the development of fraud detection and risk assessment models in the financial sector, where privacy is as important as in drug discovery.
In this way, FLock.io's privacy protection technology has the potential to be the key to breaking down "data walls" in a variety of industries.
Comparison with competitors: What makes FLock.io different?
There are several other projects in the fields of "decentralized AI" and "data ecosystems," such as "Ocean Protocol," which aims to create a marketplace where data can be bought and sold safely, and "Fetch.ai," which is building a network of autonomous AI agents.
While these projects also have impressive technology, FLock.io's clear strength is thatSpecializing in the highly specialized and impactful fields of biomedicine and drug discovery" The fact that we have teamed up with a strong partner like AIGEN Science and have a clear goal of solving a specific problem (privacy issues in drug discovery) is a major difference from other general-purpose projects. This expertise and specificity will be a powerful driving force to accelerate adoption in the real world.
Risks and Cautions: What you need to know
Even with such a promising project, there are some risks and considerations to be aware of when considering investing or getting involved.
- Technical challenges: Federated learning and blockchain are still new technologies, and unexpected technical hurdles may emerge before they can be put to large-scale practical use.
- Regulatory risks: Both medical and financial (cryptocurrency) fields are subject to strict regulations in each country. The introduction of new regulations in the future may affect the operation of the project.
- Market volatility: If FLock.io issues tokens, their prices may be significantly affected by the overall trends of the cryptocurrency market and may be subject to extreme volatility.
- Scam Warning: Scammers may appear around popular projects using fake websites, social media accounts, and fake airdrops, so always get information from the official websites.
Expert Opinions and Latest News
This partnership has already been covered by several industry media outlets, indicating the high level of attention it is receiving. Media outlets such as Korea IT Times and Metaverse Post have highlighted the strategic partnership as "breaking down data privacy barriers in biomedical AI."
The latest important news is, of course, "FLock.io and AIGEN Science sign MOU (Memorandum of Understanding)" Although the MOU is not legally binding, it shows the strong will of the two companies to cooperate seriously and is an important milestone that signifies that the project has entered the implementation stage rather than merely being a concept. This partnership connects AIGEN Science's drug discovery engine with FLock.io's infrastructure, paving the way for hospitals and research institutions to participate in data utilization with peace of mind.
Summary: Towards a future where privacy and AI coexist
This time, we talked about how the partnership between FLock.io and AIGEN Science is poised to change the world of drug discovery.
- problem: Privacy issues have made it difficult to use medical data in AI development.
- solution: FLock.io's "federated learning" technology allows AI to train without moving the data.
- Impact: We aim to speed up drug discovery and reduce costs, thereby contributing to future medical care.
- Future Prospects: This has applications not only in drug discovery but also in many other industries where privacy is important.
This project is not just about new technology. It offers a powerful answer to the previously difficult challenges of "protecting individual privacy" and "utilizing data for the benefit of society as a whole." Although it is a challenge that has just begun, it is a very exciting project that has the potential to have a significant positive impact on our health and future.
Frequently Asked Questions (FAQ)
- Q1: What is FLock.io in one word?
- A1: It is a "privacy-preserving AI learning system" that can make AI smarter while safely protecting personal privacy (especially medical data, etc.).
- Q2: Why is this technology important in drug discovery?
- A2: New drug development requires a huge amount of data, but collecting it has been difficult due to privacy issues. This technology could dramatically speed up drug discovery, as it would enable valuable data held by hospitals and other institutions to be used in research and development without the risk of privacy leaks.
- Q3: Does this have anything to do with cryptocurrencies?
- A3: Yes, there is a connection. We use blockchain technology to ensure the security and transparency of the system, and in the future, we may use our own tokens to support economic activity within the project.
- Q4: Is this project safe?
- A4: Technically, the project is designed with data security as the top priority. However, any new technology or investment comes with risks. If you are interested in the project, it is important to gather information yourself.
Links
For more information, please check out the official website below.
Disclaimer: This article is for informational purposes only and is not investment advice. Investing in cryptocurrencies and related projects carries a high degree of risk. Please do your own research (DYOR – Do Your Own Research) before making any decisions.